Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
作者信息
Larsen Christopher P, Freedman Barry I
机构信息
Nephropath, Little Rock, Arkansas; and
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
出版信息
J Am Soc Nephrol. 2015 Jun;26(6):1232-5. doi: 10.1681/ASN.2014101052. Epub 2015 Jan 8.
Abstract
摘要
相似文献
1
Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
J Am Soc Nephrol. 2015 Jun;26(6):1232-5. doi: 10.1681/ASN.2014101052. Epub 2015 Jan 8.
2
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
J Am Soc Nephrol. 2015 Jun;26(6):1443-8. doi: 10.1681/ASN.2013111242. Epub 2015 Jan 8.
3
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.
4
Immunity unmasks APOL1 in collapsing glomerulopathy.
Kidney Int. 2015 Feb;87(2):270-2. doi: 10.1038/ki.2014.325.
5
Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):262-70. doi: 10.2215/CJN.07490715. Epub 2015 Dec 14.
6
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
J Am Soc Nephrol. 2011 Nov;22(11):1991-6. doi: 10.1681/ASN.2011040434. Epub 2011 Oct 13.
7
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5.
8
APOL1 localization in normal kidney and nondiabetic kidney disease.
J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.
9
Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
West Afr J Med. 2012 Oct-Dec;31(4):273-6.
10
Familial FSGS.
Adv Chronic Kidney Dis. 2014 Sep;21(5):422-5. doi: 10.1053/j.ackd.2014.06.001.
引用本文的文献
1
Brown-Norway chromosome 1 mitigates the upregulation of proinflammatory pathways in mTAL cells and subsequent age-related CKD in Dahl SS/JrHsdMcwi rats.
Am J Physiol Renal Physiol. 2023 Feb 1;324(2):F193-F210. doi: 10.1152/ajprenal.00145.2022. Epub 2022 Dec 8.
2
Is podocytopathy another image of renal affection in p-SLE?
Pediatr Rheumatol Online J. 2021 Apr 26;19(1):57. doi: 10.1186/s12969-021-00547-9.
3
Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.
Am J Pathol. 2018 Nov;188(11):2508-2528. doi: 10.1016/j.ajpath.2018.07.025. Epub 2018 Sep 8.
4
APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.
Trends Mol Med. 2018 Aug;24(8):682-695. doi: 10.1016/j.molmed.2018.05.008. Epub 2018 Jun 7.
5
Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
Kidney Int. 2017 Feb;91(2):443-450. doi: 10.1016/j.kint.2016.09.033. Epub 2016 Dec 4.
6
Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Pediatr Nephrol. 2016 Nov;31(11):2095-101. doi: 10.1007/s00467-016-3400-y. Epub 2016 Jun 4.
7
Ethnic Differences in Childhood Nephrotic Syndrome.
Front Pediatr. 2016 Apr 19;4:39. doi: 10.3389/fped.2016.00039. eCollection 2016.
8
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.
J Lipid Res. 2016 Jun;57(6):1059-73. doi: 10.1194/jlr.P061598. Epub 2016 Apr 25.
9
Lupus Podocytopathy: A Distinct Entity.
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):547-8. doi: 10.2215/CJN.01880216. Epub 2016 Mar 16.
10
The Role of Autophagy in Lupus Nephritis.
Int J Mol Sci. 2015 Oct 22;16(10):25154-67. doi: 10.3390/ijms161025154.
本文引用的文献
1
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
J Am Soc Nephrol. 2015 Jun;26(6):1443-8. doi: 10.1681/ASN.2013111242. Epub 2015 Jan 8.
2
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
Kidney Int. 2015 Feb;87(2):332-42. doi: 10.1038/ki.2014.270. Epub 2014 Aug 6.
3
Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
Mod Pathol. 2015 Jan;28(1):95-102. doi: 10.1038/modpathol.2014.92. Epub 2014 Aug 1.
4
Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression.
J Am Soc Nephrol. 2015 Jan;26(1):230-6. doi: 10.1681/ASN.2013111155. Epub 2014 Jul 24.
5
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5.
6
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F326-36. doi: 10.1152/ajprenal.00647.2013. Epub 2014 Jun 4.
7
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220.
8
Gene-gene interactions in APOL1-associated nephropathy.
Nephrol Dial Transplant. 2014 Mar;29(3):587-94. doi: 10.1093/ndt/gft423. Epub 2013 Oct 24.
9
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Kidney Int. 2013 Dec;84(6):1207-13. doi: 10.1038/ki.2013.173. Epub 2013 May 15.
10
Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
J Am Soc Nephrol. 2013 Apr;24(5):722-5. doi: 10.1681/ASN.2012121180. Epub 2013 Mar 21.
Zotero 插件